Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb;32(1):6-15.
doi: 10.21315/mjms-09-2024-691. Epub 2025 Feb 28.

Multidrug-Resistant Candida auris and its Role in Carcinogenesis: A Scoping Review

Affiliations
Review

Multidrug-Resistant Candida auris and its Role in Carcinogenesis: A Scoping Review

Wan NurHazirah Wan Ahmad Kamil et al. Malays J Med Sci. 2025 Feb.

Abstract

Candida auris was listed as a critical fungal priority group pathogen by the World Health Organization (WHO) in 2022. It has become a leading cause of invasive candidiasis in serious nosocomial infections globally. While Candida species, particularly C. albicans, are linked to cancer development, the role of C. auris in carcinogenesis remains unexplored. This scoping review aimed to evaluate the existing evidence on the role of C. auris infection in carcinogenesis and its associated risk factors. Following the PRISMA-ScR guidelines, a comprehensive search of three databases was conducted from January 2003 to January 2024 to identify studies addressing the role of C. auris infection in cancer development and its associated risk factors. A total of 124 articles were identified, of which six met the inclusion criteria. These studies reported the risk factors associated with C. auris infection in cancer patients. The findings showed an increased susceptibility of cancer patients to C. auris infections. However, to date, no direct relationship has been reported between C. auris infection and cancer development due to the limited accuracy of diagnostic tools. In conclusion, C. auris infections increase the susceptibility of cancer patients but are not directly involved in carcinogenesis, indicating the urgency for an accurate diagnostic tool for C. auris detection and specialised infection-control measures for cancer patients.

Keywords: Candida auris; cancer; carcinogenesis; multidrug resistance; nosocomial infection; risk factors.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None.

Figures

Figure 1
Figure 1
Flowchart illustrating the process following the PRISMA Sc-R guidelines
Figure 2
Figure 2
Risk factors associated with Candida auris infection

Similar articles

References

    1. WHO Antimicrobial Resistance Division (AMR) WHO fungal priority pathogens list to guide research, development and public health action [Internet] Geneva: World Health Organization; 2022. [Retrieved 2024 Aug 12]. Available at: https://www.who.int/publications/i/item/9789240060241.
    1. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–44. doi: 10.1111/j.1348-0421.2008.00083.x. - DOI - PubMed
    1. Mohd Tap R, Lim TC, Kamarudin NA, Ginsapu SJ, Abd Razak MF, Ahmad N, et al. A fatal case of Candida auris and Candida tropicalis candidemia in neutropenic patient. Mycopathologia. 2018;183(3):559–564. doi: 10.1007/s11046-018-0244-y. - DOI - PMC - PubMed
    1. Cortegiani A, Misseri G, Chowdhary A. What’s new on emerging resistant Candida species. Intensive Care Med. 2019;45(4):512–515. doi: 10.1007/s00134-018-5363-x. - DOI - PubMed
    1. Pallotta F, Viale P, Barchiesi F. Candida auris: the new fungal threat. Infez Med. 2023;31(3):323–328. doi: 10.53854/liim-3102-12. - DOI - PMC - PubMed

LinkOut - more resources